Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Shares Outstanding (2016 - 2025)

STRATA Skin Sciences' Shares Outstanding history spans 13 years, with the latest figure at $5.3 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 26.31% year-over-year to $5.3 million; the TTM value through Sep 2025 reached $5.3 million, up 26.31%, while the annual FY2024 figure was $4.2 million, 18.97% up from the prior year.
  • Shares Outstanding for Q3 2025 was $5.3 million at STRATA Skin Sciences, up from $4.2 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $34.7 million in Q1 2022 and bottomed at $3.5 million in Q4 2022.
  • The 5-year median for Shares Outstanding is $4.2 million (2024), against an average of $15.1 million.
  • The largest annual shift saw Shares Outstanding crashed 89.95% in 2023 before it grew 26.31% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $34.4 million in 2021, then crashed by 89.9% to $3.5 million in 2022, then grew by 0.97% to $3.5 million in 2023, then grew by 18.97% to $4.2 million in 2024, then increased by 26.31% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Shares Outstanding are $5.3 million (Q3 2025), $4.2 million (Q2 2025), and $4.2 million (Q1 2025).